Skip to main content
SpringerLink
Log in

Risk of serious infections in denosumab-treated patients

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Diker-Cohen T, et al. Risk for Infections During Treatment With Denosumab for Osteoporosis: a Systematic Review and Meta-analysis. Journal of Clinical Endocrinology and Metabolism : 3 Jan 2020. Available from: URL: http://doi.org/10.1210/clinem/dgz322

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Risk of serious infections in denosumab-treated patients. Reactions Weekly 1787, 11 (2020). https://doi.org/10.1007/s40278-020-73649-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-020-73649-0

Search

Navigation